News & Updates

Show Multimedia Only
Scalp cooling reduces chemo-induced alopecia in gynaecological cancers
Scalp cooling reduces chemo-induced alopecia in gynaecological cancers
04 May 2026 byKanas Chan

Scalp cooling (or scalp hypothermia) reduces chemotherapy-induced alopecia, alleviates psychological distress, and improves quality of life (QoL) in patients with primary gynaecologic cancers receiving carboplatin plus paclitaxel, the single-centre, randomized controlled CHARM trial has shown. 

Scalp cooling reduces chemo-induced alopecia in gynaecological cancers
04 May 2026
Maternal RSV vax cuts infant hospitalization risk in real-world study
Maternal RSV vax cuts infant hospitalization risk in real-world study
30 Apr 2026